... Editas Medicine (NASDAQ:EDIT): +136.8% Intellia Therapeutics (NASDAQ:NTLA): +270.8%, CRISPR Therapeutics (NASDAQ:CRSP): +151.4%.
Source link

Leave a Reply
You must be logged in to post a comment.
... Editas Medicine (NASDAQ:EDIT): +136.8% Intellia Therapeutics (NASDAQ:NTLA): +270.8%, CRISPR Therapeutics (NASDAQ:CRSP): +151.4%.
Source link
You must be logged in to post a comment.